224 related articles for article (PubMed ID: 26244648)
1. Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study.
Ditisheim S; Fournier N; Juillerat P; Pittet V; Michetti P; Gabay C; Finckh A;
Inflamm Bowel Dis; 2015 Nov; 21(11):2598-604. PubMed ID: 26244648
[TBL] [Abstract][Full Text] [Related]
2. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
[TBL] [Abstract][Full Text] [Related]
3. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
Vavricka SR; Brun L; Ballabeni P; Pittet V; Prinz Vavricka BM; Zeitz J; Rogler G; Schoepfer AM
Am J Gastroenterol; 2011 Jan; 106(1):110-9. PubMed ID: 20808297
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
[TBL] [Abstract][Full Text] [Related]
5. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
[TBL] [Abstract][Full Text] [Related]
6. Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.
Herzog D; Fournier N; Buehr P; Rueger V; Koller R; Heyland K; Nydegger A; Spalinger J; Schibli S; Petit LM; Braegger CP;
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):598-607. PubMed ID: 29360691
[TBL] [Abstract][Full Text] [Related]
7. Smoking is associated with risk for developing inflammatory bowel disease including late onset ulcerative colitis: a prospective study.
Salih A; Widbom L; Hultdin J; Karling P
Scand J Gastroenterol; 2018 Feb; 53(2):173-178. PubMed ID: 29262738
[TBL] [Abstract][Full Text] [Related]
8. Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.
Tadbiri S; Peyrin-Biroulet L; Serrero M; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Gilletta C; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Fumery M; Claudepierre P; Bouhnik Y; Amiot A;
Aliment Pharmacol Ther; 2018 Feb; 47(4):485-493. PubMed ID: 29250803
[TBL] [Abstract][Full Text] [Related]
9. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.
Carpio D; Barreiro-de Acosta M; Echarri A; Pereira S; Castro J; Ferreiro R; Lorenzo A;
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1030-7. PubMed ID: 26049704
[TBL] [Abstract][Full Text] [Related]
10. The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.
Hiller A; Biedermann L; Fournier N; Butter M; Vavricka SR; Ciurea A; Rogler G; Scharl M;
PLoS One; 2019; 14(4):e0211554. PubMed ID: 31039159
[TBL] [Abstract][Full Text] [Related]
11. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.
Halling ML; Kjeldsen J; Knudsen T; Nielsen J; Hansen LK
World J Gastroenterol; 2017 Sep; 23(33):6137-6146. PubMed ID: 28970729
[TBL] [Abstract][Full Text] [Related]
12. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P
World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659
[TBL] [Abstract][Full Text] [Related]
13. Mucocutaneous manifestations in inflammatory bowel disease.
Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N
Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896
[TBL] [Abstract][Full Text] [Related]
14. High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort Study.
Biedermann L; Fournier N; Misselwitz B; Frei P; Zeitz J; Manser CN; Pittet V; Juillerat P; von Känel R; Fried M; Vavricka SR; Rogler G;
J Crohns Colitis; 2015 Oct; 9(10):819-29. PubMed ID: 26116554
[TBL] [Abstract][Full Text] [Related]
15. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
Shapiro JM; Zoega H; Shah SA; Bright RM; Mallette M; Moniz H; Grabert SA; Bancroft B; Merrick M; Flowers NT; Samad Z; Lidofsky S; LeLeiko NS; Sands BE
Inflamm Bowel Dis; 2016 Jun; 22(6):1456-61. PubMed ID: 26926039
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
[TBL] [Abstract][Full Text] [Related]
18. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
Ott C; Takses A; Obermeier F; Schnoy E; Müller M
World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
[TBL] [Abstract][Full Text] [Related]
19. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL
World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
Roth N; Biedermann L; Fournier N; Butter M; Vavricka SR; Navarini AA; Rogler G; Scharl M;
PLoS One; 2019; 14(1):e0210436. PubMed ID: 30682031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
